Skip to main content
. 2021 Jun 12;7:16. doi: 10.1186/s40794-021-00145-3

Table 2.

The results of laboratory findings

Test Name Unit Reference Range Case 1 Case 2 Case 3
BUN mg/dl 7–16.8 24 Hi 28 Hi 20
Ca mg/dl 8.6–10.3 8.5 Low
p mg/dl 2.7–4.5 4.9 Hi
Na (ser) mEq/L 138–145 139 139 140
K (ser) mEq/L 3.6–5.9 4.3 4.3 3.7
MCH pg 27.5–33.2 28.2 28.2 32.5
MCHC g/dL 30.0–38.0 34.6 31.6 32.6
Plt × 1000/μL 140–440 252 167 72
Cr mg/dl male:0.8–1.3 mg/dl 1 1.1 1.4 Hi
SGOT (AST) IU/L Male:< 40 86 Hi 109 Hi
SGPT (ALT) IU/L Male:< 45 46 Hi 55 Hi
WBC ×1000/μL 4.4–11 3.5 Low 8.6 8
RBC ×1,000,000/μL male:4.5–6.5 4.25 Low 4.04 Low 4.19 Low
Hb g/dl male:14–17 12 Low 14.2 13.6 Low
Hct % male:41.5–50.4 34.7 Low 45.0 41.7
MCV fl 80–96 81.6 89.3 99.5
ALK.P IU/L Male:0–270 617 Hi 280 Hi
CRP mg/L 0–6 65 Hi
ESR mm 5–12 55 Hi
D-Dimer ng/ml Normal< 200 < 200
CPK IU/L Male:0–171 617 Hi 350 Hi
LDH U/L Male:235–470 810 Hi 650 Hi
Troponin 1 Negative Negative
BS mg/dl 126 127
P.T.T sec 26–38 s 29 30
PT 11–13 s 13.6 15
INR 1.2 1.6
PT Control % 12 11
Amylase IU/L < 100 U/L 98
HBSAg CLIA MIU/ml < 1 non reactive> = 1 reactive Negative Negative Negative
HCV-Ab CLIA MIU/ml < 1 non reactive> = 1 reactive Negative Negative Negative
HIV-Ab CLIA MIU/ml < 1 non reactive> = 1 reactive Negative Negative Negative